A phase I study of the single-agent CDK4/6 inhibitor LEE011 in pts with advanced solid tumors and lymphomas.
Jeffrey R. Infante
No relevant relationships to disclose
Geoffrey Shapiro
Research Funding - Funding to Dana Farber for the conduct of the study
Petronella Witteveen
No relevant relationships to disclose
John F. Gerecitano
No relevant relationships to disclose
Vincent Ribrag
No relevant relationships to disclose
Rashmi Chugh
Research Funding - Novartis
Isra Issa
Employment or Leadership Position - Novartis
Abhijit Chakraborty
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Alessandro Matano
Employment or Leadership Position - Novartis
Xumei Zhao
Employment or Leadership Position - Novartis
Sudha Parasuraman
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Phillipe Cassier
Consultant or Advisory Role - SERVIER
Honoraria - GlaxoSmithKline; Novartis
Research Funding - Novartis; Roche
Other Remuneration - Novartis; SERVIER